Pulse Biosciences (PLSE) FCF Margin (2021 - 2025)

Pulse Biosciences' FCF Margin history runs 3 years deep, the most recent figure standing at 15377.91% for Q3 2025.

• In Q3 2025, FCF Margin changed N/A year-over-year to 15377.91%; the TTM figure through Sep 2025 stood at 56598.84% (changed N/A YoY), while the FY2022 annual figure was 6773.43%, down 292759.0% from the prior year.
• FCF Margin was 15377.91% for Q3 2025 at Pulse Biosciences, down from 88955.56% in the prior quarter.
• In the past five years, FCF Margin ranged from a high of 88955.56% in Q4 2022 to a low of 15377.91% in Q3 2025.
• Historically, FCF Margin has averaged 10308.21% across 3 years, with a median of 2964.07% in 2021.
• Biggest YoY gain for FCF Margin was 9047546 bps in 2022; the steepest drop was 9047546 bps in 2022.
• A 3-year view of FCF Margin shows it stood at 1519.91% in 2021, then surged by 5953 bps to 88955.56% in 2022, then tumbled by 117 bps to 15377.91% in 2025.
• The last three FCF Margin figures came in at 15377.91% (Q3 2025), 88955.56% (Q4 2022), and 4280.33% (Q2 2022), per Business Quant data.